Alpha Tau Medical (DRTS) stock

Radiation therapy , market cap $1.2B

Localized radiation therapy for solid tumors

Market cap $1.2B

$13.54

+5.53%

As of Tuesday's close · Live for Pro members at the open

Quality Score

Below Average

In its industry

#41of 85

Medical Devices

Checks firing

2of 14

Trending up

From 52-week high

-14.2%

Above the 200-day

DRTS's Quality Score rose 2 points on Tue, Nov 3, to 5. It closed near its high of the day (2 chart checks started).

See DRTS's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on DRTS

Key facts on DRTS
Holding it back	A $43M loss wider than $32M a year earlier
Latest filing	10-Q, Mar 9 Filed its quarterly report (10-Q) for the quarter to Dec 31, 2025

1 more reason behind DRTS's 5, free with an account →1 more reason behind DRTS's 5, for Pro members.

DRTS in the news

TodayNo story names it yet.

What's next

Tue Dec 1: Citi Global Healthcare Conference 2026Investor conference · date confirmed.

3 more dates ahead: conferences, for Pro members.

DRTS catalysts

Coming up

After its last 3 reports it closed +6.2% on average, higher 3 of 3 times.

Why DRTS scores 5

Below Averagefor quality, not price, 2 of 14 chart checks firingWhat the Quality Score means

+2Chart checks 2 of 14 firing right now, one point each
+2Long-term trend above a rising 200-⁠day average

Run-up adds
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Size, Growth, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on DRTS and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 9:52 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when DRTS's Quality Score turns up

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on DRTS and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

DRTS has 2 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on DRTS, and all 14 on every stock.Get in free →

DRTS RSI today: 49.6, below its 50-day, above its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1449.6
Above 30, below 50.
MACD (12, 26, 9)Above signal
Crossed above its signal line today.
50-day average$14.19
The price is 4.6% below it.
200-day average$10.66
The price is 27.0% above it.
50/200 crossGolden cross
The 50-day crossed above the 200-day on Jun 6, 2025.
ADX 1425.7
25 or more, with +DI below -DI.
Support$11.99
Swing low from Oct 16, 11.4% below the price.
Resistance$13.85
Swing high from Oct 21, 2.3% above the price.
52-week high$15.79
From Sep 17, 16.6% above the price.
52-week low$3.43
From Nov 21, 2025, 74.7% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Inside
The bands run from $12.27 to $14.46.
Volume1.4x
Against its 20-day average, for the time of day.

The deep dive on DRTS

What it does and how it makes money1 findingFor Pro members1 finding on what DRTS does and how it makes money, for Pro members
Where it stands1 findingInterest expense of $347K in the year to Dec 31, 2025.Filed figures to Dec 31, 2025
Who holds and trades it2 findingsFor Pro members2 findings on who holds and trades DRTS, for Pro members

3 more findings on DRTS, each with its source, for Pro membersGet in free →

How DRTS ranks in Medical Devices

DRTS is #41 of 85 by Quality Score.

How DRTS ranks in Medical Devices
1	ATRCAtriCure	7/14	18
2	HAEHaemonetics	7/14	17
3	WSTWest Pharmaceutical Services	6/14	17
	CNXUConexeu Sciences		Open for its score
	COOThe Cooper Companies		Open for its score
	DXCMDexCom		Open for its score
	EMBCEmbecta		Open for its score
41	DRTSAlpha Tau Medical	2/14	5

When does DRTS report earnings, and what happens after?

Expected to report Thu Nov 19, after the close (in 16 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

+10.1%+1.9%+6.5%

Nov 20Mar 9May 18

Reported	When	Gap	Reaction	5 sessions
May 18, 2026After close	After close	+2.0%	+6.5%	+3.4%
Mar 9, 2026After close	After close	-0.8%	+1.9%	+8.1%
Nov 20, 2025After close	After close	-1.1%	+10.1%	+14.4%

DRTS closed higher after 3 of its last 3 reports.

Insiders trading DRTS

DRTS insider trades

One insider sold $352K across 2 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellRaphi Levy$191KChief Financial Officerat $10.90 on Jun 3, filed Jun 4

SellRaphi LevyChief Financial Officer$191Kat $10.90 on Jun 3, filed Jun 4

All 2 insider filings on DRTS from the last six months, for Pro members.Get in free →

DRTS's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Raphi LevyChief Financial Officer · 4 trades

See insider trades by person

About Alpha Tau Medical

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

121 employeesalphatau.com

DRTS's score card

Alpha Tau Medical (DRTS): Quality Score 5, Below Average, #41 of 85 in Medical Devices, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn DRTS's score around: 4 things
3 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayJun 4Raphi Levy sold DRTS$191K at $10.90, filed Jun 4

Alerts are optional.

See DRTS's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 3, 2026: DRTS's Quality Score is 5 (Below Average), #41 of 85 in Medical Devices. Insiders sold $352K in the last 6 months (Form 4).

Is DRTS a good stock to buy? What its Quality Score says

DRTS scores 5 today, which Breakaway calls Below Average. It is #41 of 85 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Shares: 15.2% more than a year ago (to Dec 31). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is DRTS's Quality Score?

DRTS scores 5 today, which Breakaway calls Below Average (0 to 5). That is #41 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind DRTS's 5.

Are insiders buying DRTS?

One insider sold $352K across 2 filings in the last 6 months. No open-⁠market buys on record. The newest is Raphi Levy, Chief Financial Officer, who sold $191K on Jun 3. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.